{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:07:50Z","timestamp":1792670870646,"version":"4.5.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1097\/inf.0b013e318268dfe4","type":"journal-article","created":{"date-parts":[[2012,7,19]],"date-time":"2012-07-19T09:14:18Z","timestamp":1342689258000},"page":"1173-1183","source":"Crossref","is-referenced-by-count":51,"title":["Safety and Immunogenicity of a Quadrivalent Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Infants and Toddlers"],"prefix":"10.1097","volume":"31","author":[{"given":"L. Miriam","family":"Pina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehab","family":"Bassily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Machmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Reinhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"suppl 2","key":"R2-20-20210202","doi-asserted-by":"crossref","first-page":"B51","DOI":"10.1016\/j.vaccine.2009.04.063","article-title":"Global epidemiology of meningococcal disease.","volume":"27","author":"Harrison","year":"2009","journal-title":"Vaccine"},{"key":"R3-20-20210202","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1086\/649209","article-title":"Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease.","volume":"50","author":"Cohn","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R7-20-20210202","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1086\/367858","article-title":"Hajj-associated outbreak strain of Neisseria meningitidis serogroup W135: estimates of the attack rate in a defined population and the risk of invasive disease developing in carriers.","volume":"36","author":"Wilder-Smith","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R8-20-20210202","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1046\/j.1440-1754.2001.00679.x","article-title":"Meningococcal disease and vaccination in North America.","volume":"37","author":"Pollard","year":"2001","journal-title":"J Paediatr Child Health"},{"key":"R10-20-20210202","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1128\/JCM.02390-08","article-title":"W135 invasive meningococcal strains spreading in South America: significant increase in incidence rate in Argentina.","volume":"47","author":"Efron","year":"2009","journal-title":"J Clin Microbiol"},{"key":"R11-20-20210202","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3201\/eid1601.091026","article-title":"Cluster of serogroup W135 meningococci, southeastern Florida, 2008-2009.","volume":"16","author":"Doyle","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"R12-20-20210202","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1586\/14760584.5.4.445","article-title":"Experience with MCV-4, a meningococcal, diphtheria toxoid conjugate vaccine against serogroups A, C, Y and W-135.","volume":"5","author":"Keyserling","year":"2006","journal-title":"Expert Rev Vaccines"},{"issue":"suppl 2","key":"R13-20-20210202","doi-asserted-by":"crossref","first-page":"B30","DOI":"10.1016\/j.vaccine.2009.05.003","article-title":"Quadrivalent meningococcal conjugate vaccines.","volume":"27","author":"Pace","year":"2009","journal-title":"Vaccine"},{"key":"R19-20-20210202","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral antibodies.","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"key":"R20-20-20210202","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1084\/jem.129.6.1327","article-title":"Human immunity to the meningococcus. II. Development of natural immunity.","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"key":"R24-20-20210202","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group.","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"R26-20-20210202","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0891-5520(05)70311-1","article-title":"Assays for antibodies to varicella-zoster virus.","volume":"10","author":"Krah","year":"1996","journal-title":"Infect Dis Clin North Am"},{"key":"R27-20-20210202","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/infdis\/130.6.669","article-title":"Serologic response to varicella-zoster membrane antigens measured by direct immunofluorescence.","volume":"130","author":"Williams","year":"1974","journal-title":"J Infect Dis"},{"key":"R30-20-20210202","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1128\/CDLI.4.4.415-422.1997","article-title":"Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells.","volume":"4","author":"Romero-Steiner","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"R31-20-20210202","doi-asserted-by":"crossref","first-page":"866","DOI":"10.4049\/jimmunol.120.3.866","article-title":"Intrinsic tritium labeling of the capsular polysaccharide antigen of Haemophilus influenzae type B.","volume":"120","author":"Anderson","year":"1978","journal-title":"J Immunol"},{"key":"R32-20-20210202","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/infdis\/134.5.495","article-title":"Serologic responses of children with meningitis due to Haemophilus influenzae type b.","volume":"134","author":"Norden","year":"1976","journal-title":"J Infect Dis"},{"key":"R35-20-20210202","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1016\/j.vaccine.2010.06.026","article-title":"Glycoconjugate vaccines and immune interference: A review.","volume":"28","author":"Dagan","year":"2010","journal-title":"Vaccine"},{"key":"R36-20-20210202","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.vaccine.2009.10.064","article-title":"A dose-range study assessing immunogenicity and safety of one dose of a new candidate meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate (MenACWY-TT) vaccine administered in the second year of life and in young children.","volume":"28","author":"Knuf","year":"2010","journal-title":"Vaccine"},{"key":"R37-20-20210202","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/jama.2007.29-c","article-title":"Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.","volume":"299","author":"Snape","year":"2008","journal-title":"JAMA"},{"key":"R38-20-20210202","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1128\/CDLI.12.8.970-976.2005","article-title":"Interlaboratory standardization of the measurement of serum bactericidal activity by using human complement against meningococcal serogroup b, strain 4476-SL, before and after vaccination with the Norwegian MenBvac outer membrane vesicle vaccine.","volume":"12","author":"Borrow","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"R39-20-20210202","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(12)70087-7","article-title":"Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial.","volume":"12","author":"Richmond","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"suppl 2","key":"R41-20-20210202","doi-asserted-by":"crossref","first-page":"B20","DOI":"10.1016\/j.vaccine.2009.04.067","article-title":"Meningococcal C conjugate vaccine: the experience in England and Wales.","volume":"27","author":"Campbell","year":"2009","journal-title":"Vaccine"},{"key":"R42-20-20210202","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/INF.0b013e31819040e7","article-title":"Canadian Immunization Monitoring Program, Active (IMPACT). The impact of childhood meningococcal serogroup C conjugate vaccine programs in Canada.","volume":"28","author":"Bettinger","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R43-20-20210202","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/01.inf.0000195594.41449.c6","article-title":"Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands.","volume":"25","author":"de Greeff","year":"2006","journal-title":"Pediatr Infect Dis J"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0b013e318268dfe4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T10:19:50Z","timestamp":1687601990000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201211000-00020"}},"subtitle":["Three Multicenter Phase III Studies"],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e318268dfe4","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717953011.793458560","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717953011.793459526","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717953011.793460567","asserted-by":"object"}]},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}